Health By Elizabeth Cooney Covid-19 infections leave an impact on the heart, raising concerns about lasting damage
First Opinion By Larry Husten Beware the hype over the Apple Watch heart app. The device could do more harm than good
Health By Ruth Hailu Patients whose blood pressure only spikes at the doctor’s office are twice as likely to die of a heart attack or other cardiac event
Health By Shraddha Chakradhar ‘Donation after cardiac death’: New heart transplant method being tested for the first time in the U.S.
Health Tech By Erin Brodwin Blood pressure and cholesterol checks are ‘falling through the cracks’ of virtual primary care
Health By Pratibha Gopalakrishna New research shows older adults are still often excluded from clinical trials
In the Lab By Pratibha Gopalakrishna In research on pigs, scientists test a new way to boost recovery after a heart attack
In the Lab By Sharon Begley In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Health Tech By Erin Brodwin Fueled by the Covid-19 pandemic, remote heart monitoring could become tech’s next big target
Pharma By Ed Silverman Pharmalittle: Hackers linked to Iran sought Gilead Covid-19 data; NIH to test remdesivir with a Lilly drug
Pharmalot By Ed Silverman Pharmalittle: Hospitals criticize feds over remdesivir supplies; Moderna starting mid-stage Covid-19 vaccine trials soon
Health Tech By Casey Ross In fading steel towns, chronically ill patients hope video visits stay after the pandemic goes
Health By Usha Lee McFarling ‘Where are all our patients?’: Covid phobia is keeping people with serious heart symptoms away from ERs
Health By Elizabeth Cooney Blood clots in severe Covid-19 patients leave clinicians with clues about the illness — but no proven treatments
In the Lab By Elizabeth Cooney MIT’s Koch Institute wins STAT Madness with technology to see tiny ovarian tumors
Health By Matthew Herper New drug from Merck, Bayer reduces hospitalizations for heart failure patients
Health Tech By Rebecca Robbins The coronavirus is imperiling drug studies. A virtual study of the Apple Watch could be positioned to thrive
Health By Karen Weintraub Her son died. Two decades later, she met the medical student who got his heart
Pharma By Phil Galewitz — Kaiser Health News Heart association admits ‘misstep’ in its drug-store aspirin displays with Bayer
Health Tech By Casey Ross AI has arrived in medical imaging. Now the FDA needs to monitor its impact on patients
Biotech By Matthew Herper After 21-year journey, Esperion to test market for a cholesterol pill that is less expensive than some competitors
Health By Eric Boodman How the psychology of a $4.99 price tag might influence who undergoes heart surgery
Health By Matthew Herper FDA approves AI-based software that helps doctors take ultrasound pictures of the heart
Pharmalot By Ed Silverman Years later, raw clinical trial data tells us the extent of Avandia’s heart risks
Biotech By Adam Feuerstein Regeneron’s Yancopoulos is still bitter over Praluent sales. Can Novartis do better?